Name | Recombinant Human Semaphorin 3E Protein, CF |
---|---|
Supplier | R&D Systems |
Catalog | 3239-S3 |
Category | Protein |
Prices | $329.00 |
Sizes | 25 µg |
Species Reactivities | Human |
Nature | Recombinant |
Source | Mouse myeloma cell line, NS0-derived Thr25-Ser775 (Arg557Ala and Arg560Ala), with an N-terminal 10-His tag |
Purity | >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Bioactivity | Measured by its ability to inhibit the proliferation of HUVEC human umbilical vein endothelial cells. Moriya, J. et al . (2010) Circ. Res. 106 :391. The ED 50 for this effect is typically 0.3-1.5 μg/mL. Measured by its binding ability in a functional ELISA. When Recombinant Human Plexin D1 (Catalog # 4160-PD ) is coated at 5 μg/mL, Recombinant Human Semaphorin 3E binds with an apparent K D <2 nM. |
Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
SwissProt/Accession | O15041 |
Gene | SEMA3E |
Sequence | His |
Supplier Page | Shop |
Fukushima Y, Okada M, Kataoka H, Hirashima M, Yoshida Y, Mann F, Gomi F, Nishida K, Nishikawa S, Uemura A. J Clin Invest. 2011 May;121(5):1974-85.
Kusuhara S, Fukushima Y, Fukuhara S, Jakt LM, Okada M, Shimizu Y, Hata M, Nishida K, Negi A, Hirashima M, Mochizuki N, Nishikawa S, Uemura A. PLoS One. 2012;7(9):e45858.
Meda C, Molla F, De Pizzol M, Regano D, Maione F, Capano S, Locati M, Mantovani A, Latini R, Bussolino F, Giraudo E. J Immunol. 2012 Apr 15;188(8):4081-92.